Search

Displaying results 5151 - 5160 of 7706 in total
  1. Drug

    Ioprocemic acid

    go.drugbank.com/drugs/DB20503
    Experimental

    Ioprocemic acid has a monoisotopic molecular weight of 612.81 Da.

  2. Drug

    Broxitalamic acid

    go.drugbank.com/drugs/DB20561
    Experimental

    Broxitalamic acid has a monoisotopic molecular weight of 499.82 Da.

  3. Drug

    Aceburic acid

    go.drugbank.com/drugs/DB20668
    Experimental

    Aceburic acid has a monoisotopic molecular weight of 146.06 Da.

  4. Drug

    Tiazotic acid

    go.drugbank.com/drugs/DB21408
    Experimental

    Tiazotic acid has a monoisotopic molecular weight of 173.03 Da.

  5. Drug

    Oxiniacic acid

    go.drugbank.com/drugs/DB21422
    Experimental

    Oxiniacic acid has a monoisotopic molecular weight of 139.03 Da.

  6. Drug

    (S)-camphor

    go.drugbank.com/drugs/DB11345
    Approved

    It has been used as a nasal decongestant and cough suppressant, and has been topically applied due to its antipruritic, analgesic, and counterirritant properties [A33086].

    Mixtures: U Ice Cold, U Ice Cold
  7. Drug

    Matrix-M

    go.drugbank.com/drugs/DB16369
    Investigational

    Matrix-M is a saponin-based adjuvant made of nanometer particles, cholesterol, and phospholipid that is developed by Novavax. This compound is administered alongside vaccines to enhance biological functions: creating robust and long-last...

  8. Drug

    Dimethyltryptamine

    go.drugbank.com/drugs/DB01488
    IllicitInvestigational

    It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others. … An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine.

  9. Drug

    Bos taurus gallstone

    go.drugbank.com/drugs/DB14248
    Investigational

    Bos taurus gallstone is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

  10. Drug

    BRD-810

    go.drugbank.com/drugs/DB23607
    Experimental

    BRD-810 is an experimental small molecule being investigated as a potential anti-cancer medication. It is an inhibitor of the protein myeloid cell leukemia 1 (MCL1). [A274263]